Mark Cuban Cost Plus Drug Co.
Latest
Pharmaceuticals
Newsweek Calls Mark Cuban Cost Plus Drug Co. a ‘Medical Marvel’
The innovative pharmaceutical company is one of ten disruptive healthcare innovators named by the magazine.
Pharmaceuticals
Mark Cuban: Business Is How We Teach Washington What Works
At the Dallas Regional Chamber's annual meeting, he discussed how his pharmaceutical company is doing to drug prices what government regulation has been unable to do.
Innovation Awards
Winners Announced: The Innovation Awards
Presented by D CEO and Dallas Innovates, honorees in this year's program include David C. Williams of AT&T, Tricia D'Cruz of Catalyze Dallas, Celanese Corp, Hedera and Swirlds, and more.
Pharmaceuticals
Mark Cuban’s Drug Company Has Entered the Employer Market
Cost Plus is partnering with a pharmacy benefit manager emphasizing transparency.
Events
Panel Recap: D CEO Healthcare’s Healthcare Policy Discussion
Panelists discuss the inflation reduction act, drug pricing, and issues yet to be addressed.
Latest
Events
Join Us for Our Next D CEO Healthcare Panel: Healthcare Policy
A U.S. Congressperson, pharmaceutical CEO, and benefits expert will dig into how policy impacts outcomes and business.
Pharmaceuticals
Why Mark Cuban Put His Name on a Drug Company
The Dallas Mavericks owner has launched and funded wildly successful ventures over the years. But this time, it’s not about the money.
Deal Ticker
Dave & Buster’s to Relocate Headquarters From Dallas to Coppell
Plus: CBRE brokers deal for new 500,000-square-foot plant, GREA sells six apartment communities, Weitzman inks new space for Ascension Coffee, and more.